---
title: "COMEFLY OUTDOOR invests in Ningbo to establish a technology company"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236505572.md"
description: "According to the Qichacha APP, recently, Ningbo COMEFLY OUTDOOR Technology Co., Ltd. was established, with Lu Tuanhua as the legal representative and a registered capital of 1 million yuan. The business scope includes: brand management; marketing planning; experiential expansion activities and planning; corporate management consulting, etc. Qichacha's equity penetration shows that the company is wholly owned by COMEFLY OUTDOOR indirectly"
datetime: "2025-04-18T01:27:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236505572.md)
  - [en](https://longbridge.com/en/news/236505572.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236505572.md)
generator: "portal-rs"
---

# COMEFLY OUTDOOR invests in Ningbo to establish a technology company

According to the Qichacha APP, recently, Ningbo COMEFLY OUTDOOR Technology Co., Ltd. was established, with Lu Tuanhua as the legal representative and a registered capital of 1 million yuan. The business scope includes: brand management; marketing planning; experiential expansion activities and planning; corporate management consulting, etc. Qichacha's equity penetration shows that the company is wholly owned by COMEFLY OUTDOOR indirectly

### Related Stocks

- [603908.CN](https://longbridge.com/en/quote/603908.CN.md)

## Related News & Research

- [Should Bravida’s SEK 850m Data Center Win and Governance Moves Require Action From Bravida Holding (OM:BRAV) Investors?](https://longbridge.com/en/news/298188102.md)
- [WFS renews China Eastern cargo handling contract at Stockholm Arlanda Airport](https://longbridge.com/en/news/298289555.md)
- [Another swarm of OpenAI agents reached the open internet without the frontier lab’s knowledge](https://longbridge.com/en/news/298059653.md)
- [Baidu’s Xiaodu schedules AI hardware launch for Sept. 8](https://longbridge.com/en/news/298171383.md)
- [Cereno Scientific says Phase IIb EPIMODE trial of CS1 in pulmonary arterial hypertension begins screening patients](https://longbridge.com/en/news/298266930.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**